journal article·2021-03-04Open access

Novel Approaches to Combat Medical Device-Associated BioFilms

Xin Li, Luyao Sun, Peng Zhang, Yang Wang

Coatings· Volume 11· Issue 3

Abstract

Biofilms are aggregates formed as a protective survival state by microorganisms to adapt to the environment and can be resistant to antimicrobial agents and host immune responses due to chemical or physical diffusion barriers, modified nutrient environments, suppression of the growth rate within biofilms, and the genetic adaptation of cells within biofilms. With the widespread use of medical devices, medical device-associated biofilms continue to pose a serious threat to human health, and these biofilms have become the most important source of nosocomial infections. However, traditional antimicrobial agents cannot completely eliminate medical device-associated biofilms. New strategies for the treatment of these biofilms and targeting biofilm infections are urgently required. Several novel approaches have been developed and identified as effective and promising treatments. In this review, we briefly summarize the challenges associated with the treatment of medical device-associated biofilm infections and highlight the latest promising approaches aimed at preventing or eradicating these biofilms.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bacterial biofilms and quorum sensing · Legionella and Acanthamoeba research · Oral microbiology and periodontitis research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Infectious Diseases, First Hospital of Jilin University, Changchun 130021, China

Funding

National Natural Science Foundation of China

References (100+)

Show source-provided references
1. Promising Therapeutic Strategies Against Microbial Biofilm Challenges10.3389/fcimb.2020.00359 ↗
2. The biofilm matrix10.1038/nrmicro2415 ↗
3. Bacterial biofilms: From the Natural environment to infectious diseases10.1038/nrmicro821 ↗
4. Quorum Sensing Influences Burkholderia thailandensis Biofilm Development and Matrix Production10.1128/JB.00047-16 ↗
5. Bacterial quorum sensing in complex and dynamically changing environments10.1038/s41579-019-0186-5 ↗
6. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes10.1111/j.1600-0463.2009.02466.x ↗
7. Biofilm dispersion and quorum sensing10.1016/j.mib.2014.02.008 ↗
8. Biofilm Formation as Microbial Development10.1146/annurev.micro.54.1.49 ↗
9. Biofilms: Survival and defense strategy for pathogens10.1016/j.ijmm.2017.09.016 ↗
10. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria10.1016/j.bbamem.2015.10.013 ↗
11. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action10.1080/21505594.2017.1313372 ↗
12. Virulence Factors Produced by Staphylococcus aureus Biofilms Have a Moonlighting Function Contributing to Biofilm Integrity10.1074/mcp.RA118.001120 ↗
13. Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era10.1101/cshperspect.a010306 ↗
14. Antibiofilm Synergy of β-Lactams and Branched Polyethylenimine against Methicillin-ResistantStaphylococcus epidermidis10.1021/acs.biomac.9b00849 ↗
15. Bacterial biofilm and associated infections10.1016/j.jcma.2017.07.012 ↗
16. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention10.1016/j.heliyon.2018.e01067 ↗
17. Implantable Device-Related Infection10.1097/SHK.0000000000000692 ↗
18. Medical biofilms10.1002/bit.21838 ↗
19. Treatment of Infections Associated with Surgical Implants10.1056/NEJMra035415 ↗
20. Carvalho, F.M., Teixeira-Santos, R., Mergulhão, F.J.M., and Gomes, L.C. (2020). The Use of Probiotics to Fight Biofilms in Medical Devices: A Systematic Review and Meta-Analysis. Microorganisms, 9.10.3390/microorganisms9010027 ↗
21. Antimicrobial Peptides as Anti-biofilm Agents in Medical Implants10.2174/1568026616666160713141439 ↗
22. Tran, H.M., Tran, H., Booth, M.A., Fox, K.E., Nguyen, T.H., Tran, N., and Tran, P.A. (2020). Nanomaterials for Treating Bacterial Biofilms on Implantable Medical Devices. Nanomaterials, 10.10.3390/nano10112253 ↗
23. Natural Anti-biofilm Agents: Strategies to Control Biofilm-Forming Pathogens10.3389/fmicb.2020.566325 ↗
24. Yasir, M., Willcox, M.D.P., and Dutta, D. (2018). Action of Antimicrobial Peptides against Bacterial Biofilms. Materials, 11.10.3390/ma11122468 ↗
25. Delcaru, C., Alexandru, I., Podgoreanu, P., Grosu, M., Stavropoulos, E., Chifiriuc, M.C., and Lazar, V. (2016). Microbial Biofilms in Urinary Tract Infections and Prostatitis: Etiology, Pathogenicity, and Combating strategies. Pathogens, 5.10.3390/pathogens5040065 ↗
26. Biofilms in ventilator-associated pneumonia10.2217/fmb-2016-0040 ↗
27. The prevalence of biofilms in chronic wounds: A systematic review and meta-analysis of published data10.12968/jowc.2017.26.1.20 ↗
28. Sampaio, J., Machado, D., Gomes, A.M., Machado, I., Santos, C., Lima, N., Carvalho, M.J., Cabrita, A., Rodrigues, A., and Martins, M. (2016). Deciphering the Contribution of Biofilm to the Pathogenesis of Peritoneal Dialysis Infections: Characterization and Microbial Behaviour on Dialysis Fluids. PLoS ONE, 11.10.1371/journal.pone.0157870 ↗
29. Central venous catheters and biofilms: Where do we stand in 2017?10.1111/apm.12665 ↗
30. Decolonization in Prevention of Health Care-Associated Infections10.1128/CMR.00049-15 ↗
31. Staphylococcus aureus and Staphylococcus epidermidis infections on implants10.1016/j.jhin.2017.11.008 ↗
32. Implant Retention or Removal for Management of Surgical Site Infection After Spinal Surgery10.1177/2192568219869330 ↗
33. Bacterial biofilm-based catheter-associated urinary tract infections: Causative pathogens and antibiotic resistance10.1016/j.ajic.2017.05.009 ↗
34. Escherichia coli biofilm: Development and therapeutic strategies10.1111/jam.13078 ↗
35. Pseudomonas aeruginosa Biofilm, a Programmed Bacterial Life for Fitness10.4014/jmb.1611.11056 ↗
36. Klebsiella pneumoniae10.1097/INF.0000000000001675 ↗
37. Acinetobacter baumannii biofilms: Effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments10.2147/IDR.S169894 ↗
38. Uncovering the mechanisms of Acinetobacter baumannii virulence10.1038/nrmicro.2017.148 ↗
39. Fighting Mixed-Species Microbial Biofilms with Cold Atmospheric Plasma10.3389/fmicb.2020.01000 ↗
40. Current understanding of multi-species biofilms10.4248/IJOS11027 ↗
41. Bacterial and Host Interactions of Oral Streptococci10.1089/dna.2009.0868 ↗
42. Biofilm on artificial pacemaker: Fiction or reality?10.1590/S0066-782X2011001400018 ↗
43. Infections of cardiovascular implantable electronic devices: 14 years of experience in an Italian hospital
44. Surgical Treatment of Pacemaker and Defibrillator Lead Endocarditis10.1378/chest.124.4.1451 ↗
45. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)10.1093/europace/euz246 ↗
46. Challenges in Infective Endocarditis10.1016/j.jacc.2016.10.066 ↗
47. Four hundred consecutive patients with permanent transvenous pacemakers10.1016/S0022-5223(19)41605-X ↗
48. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins
49. Epidemiology of Left Ventricular Assist Device Infections: Findings From a Large Nonregistry Cohort10.1093/cid/ciaa011 ↗
50. Multicenter Outbreak of Gram-Negative Bloodstream Infections in Hemodialysis Patients10.1053/j.ajkd.2019.05.012 ↗
51. Clinical Outcomes and Risk Factors for Tunneled Hemodialysis Catheter-Related Bloodstream Infections10.1093/ofid/ofaa117 ↗
52. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients10.1016/j.ajic.2003.05.007 ↗
53. Intravascular catheter-related infections in an Indian tertiary care hospital10.3855/jidc.1261 ↗
54. Bacillus cereus biofilm formation on central venous catheters of hospitalised cardiac patients10.1080/08927014.2019.1586889 ↗
55. Anti-Candida activity of antimicrobial impregnated central venous catheters10.1186/s13756-017-0269-x ↗
56. Tetrasodium EDTA Is Effective at Eradicating Biofilms Formed by Clinically Relevant Microorganisms from Patients’ Central Venous Catheters10.1128/mSphere.00525-18 ↗
57. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: The PREVAIL RCT10.3310/hta24570 ↗
58. Anti-biofilm activity of LC-MS based Solanum nigrum essential oils against multi drug resistant biofilm forming P. mirabilis10.1016/j.sjbs.2020.10.003 ↗
59. CAUTI’s next top model—Model dependent Klebsiella biofilm inhibition by bacteriophages and antimicrobials10.1016/j.bioflm.2020.100038 ↗
60. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options10.1038/nrmicro3432 ↗
61. Obručová, H., Kotásková, I., Tihelková, R., Holá, V., Růžička, F., and Freiberger, T. (2019). Fluorescent Capillary Electrophoresis Is Superior to Culture in Detecting Candida Species from Samples of Urinary Catheters and Ureteral Stents with Mono- or Polyfungal Biofilm Growth. J. Clin. Microbiol., 57.10.1128/JCM.01861-18 ↗
62. A study on device-related infections with special reference to biofilm production and antibiotic resistance10.4103/0974-777X.103896 ↗
63. Infection Risk with Nitrofurazone-Impregnated Urinary Catheters in Trauma Patients10.7326/0003-4819-147-5-200709040-00002 ↗
64. Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia
65. Biofilm formation on three different endotracheal tubes: A prospective clinical trial10.1186/s13054-020-03092-1 ↗
66. Ventilator-associated pneumonia in adults: A narrative review10.1007/s00134-020-05980-0 ↗
67. The incidence of ventilator-associated pneumonia (VAP) in a tertiary-care center: Comparison between pre- and post-VAP prevention bundle10.1016/j.jiph.2019.09.015 ↗
68. The prevalence of suspected ventilator-associated pneumonia in Scottish intensive care units10.1177/1751143719854984 ↗
69. Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 201310.1001/jama.2016.16226 ↗
70. Barbieri, R., Pesce, M., Franchelli, S., Baldelli, I., De Maria, A., and Marchese, A. (2015). Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. BMC Microbiol., 15.10.1186/s12866-015-0368-x ↗
71. Breast Augmentation, Antibiotic Prophylaxis, and Infection: Comparative Analysis of 1,628 Primary Augmentation Mammoplasties Assessing the Role and Efficacy of Antibiotics Prophylaxis Duration10.1007/s00266-009-9427-8 ↗
72. Late infection following breast augmentation with textured silicone gel–filled implants10.1016/j.asj.2005.02.006 ↗
73. Risk of infection is associated more with drain duration than daily drainage volume in prosthesis-based breast reconstruction10.1097/MD.0000000000005605 ↗
74. Biofilm forming capacity and antibiotic susceptibility of Staphylococcus spp. with the icaA/icaD/bap genotype isolated from ocular surface of patients with diabetes10.4314/mmj.v30i4.6 ↗
75. Ozone against Pseudomonas aeruginosa biofilms in contact lenses storage cases10.1590/s1678-9946201961023 ↗
76. Candida albicans and Pseudomonas aeruginosa adhesion on soft contact lenses
77. Epidemiology of contact lens-induced infiltrates: An updated review10.1111/cxo.12598 ↗
78. Bacterial colonization immediately after installation on oral titanium implants10.1111/j.1600-0501.2007.01381.x ↗
79. Biofilm and dental implant: The microbial link10.4103/0972-124X.107466 ↗
80. Presence of Candida species in the subgingival oral biofilm of patients with peri-implantitis10.1111/cid.12760 ↗
81. Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology10.1111/j.1600-051X.2008.01283.x ↗
82. Does Extracellular DNA Production Vary in Staphylococcal Biofilms Isolated from Infected Implants versus Controls?10.1007/s11999-017-5266-0 ↗
83. Moxifloxacin-rifampicin combination for the treatment of non-staphylococcal Gram-positive orthopedic implant-related infections10.1016/j.medmal.2019.06.008 ↗
84. Infection after total hip arthroplasty10.1302/0301-620X.85B7.14095 ↗
85. One-Stage Exchange Arthroplasty for Fistulizing Periprosthetic Joint Infection of the Hip: An Effective Strategy10.3389/fmed.2020.540929 ↗
86. Kunutsor, S.K., Whitehouse, M.R., Blom, A.W., Beswick, A.D., and Team, I. (2015). Re-Infection Outcomes following One- and Two-Stage Surgical Revision of Infected Hip Prosthesis: A Systematic Review and Meta-Analysis. PLoS ONE, 10.10.1371/journal.pone.0139166 ↗
87. Two-stage revision surgery for periprosthetic joint infection following total hip arthroplasty10.21037/atm.2019.12.126 ↗
88. Development of antimicrobial therapy methods to overcome the antibiotic resistance of Acinetobacter baumannii10.32607/actanaturae.10955 ↗
89. The extracellular matrix protects Pseudomonas aeruginosabiofilms by limiting the penetration of tobramycin10.1111/1462-2920.12155 ↗
90. Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa10.1128/AAC.01650-15 ↗
91. Mulcahy, H., Charron-Mazenod, L., and Lewenza, S. (2008). Extracellular DNA Chelates Cations and Induces Antibiotic Resistance in Pseudomonas aeruginosa Biofilms. PLoS Pathog., 4.10.1371/journal.ppat.1000213 ↗
92. Increased mutability of Pseudomonas aeruginosa in biofilms10.1093/jac/dkn044 ↗
93. Mechanisms and Control Measures of Mature Biofilm Resistance to Antimicrobial Agents in the Clinical Context10.1021/acsomega.0c02294 ↗
94. Biofilm Formation and Detection of Fluoroquinolone- and Carbapenem-Resistant Genes in Multidrug-ResistantAcinetobacter baumannii10.1155/2019/3454907 ↗
95. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin10.1093/jac/42.6.755 ↗
96. Role of bacterial efflux pumps in biofilm formation10.1093/jac/dky042 ↗
97. Burkholderia pseudomallei resistance to antibiotics in biofilm-induced conditions is related to efflux pumps10.1099/jmm.0.000358 ↗
98. Short communication: Roles of outer membrane protein W (OmpW) on survival and biofilm formation of Cronobacter sakazakii under neomycin sulfate stress10.3168/jds.2017-13517 ↗
99. Biofilm-specific antibiotic resistance10.2217/fmb.12.76 ↗
100. The interconnection between biofilm formation and horizontal gene transfer10.1111/j.1574-695X.2012.00960.x ↗